Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pariser

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Journal of the American Academy of Dermatology|October 4, 2005
Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparisonZoe Draelos, Anjuli Nayak, David Pariser, et al.
Journal of Drugs in Dermatology : JDD|August 21, 2018
Rapid Onset of Action in Patients With Moderate-to-Severe Plaque Psoriasis With Halobetasol 0.01%/Tazarotene 0.045% Fixed CombinationLinda Stein Gold, Leon H Kircik, David Pariser, et al.
Journal of Drugs in Dermatology : JDD|August 19, 2016
The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethasone Dipropionate Improves the Health-Related Quality of Life in Patients With Psoriasis Vulgaris: Results from the Randomized PSO-FAST StudyCraig Leonardi, Jerry Bagel, Paul Yamauchi, et al.
Journal of Drugs in Dermatology : JDD|December 15, 2015
Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients With Psoriasis Vulgaris--a Randomized Phase III Study (PSO-FAST)Craig Leonardi, Jerry Bagel, Paul Yamauchi, et al.
Journal of the American Academy of Dermatology|July 8, 2010
Long-term etanercept in pediatric patients with plaque psoriasisAmy S Paller, Elaine C Siegfried, Lawrence F Eichenfield, et al.
Dermatology and Therapy|May 11, 2025
Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient OutcomesBruce E Strober, Michael Bukhalo, April W Armstrong, et al.
Dermatology and Therapy|December 9, 2017
Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 StudiesDavid Pariser, Ellen Frankel, Joel Schlessinger, et al.
The Journal of Clinical and Aesthetic Dermatology|October 10, 2022
The Future of Contract Research Organizations in Dermatology and Aesthetic ResearchMark Nestor, David Pariser, James Del Rosso, et al.
The Journal of Clinical and Aesthetic Dermatology|January 2, 2023
The Future of Contract Research Organizations in Dermatology and Aesthetic ResearchMark Nestor, David Pariser, James Del Rosso, et al.
BMC Dermatology|May 9, 2015
Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasisFernando Valenzuela, Kim A Papp, David Pariser, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Journal of the American Academy of Dermatology|October 4, 2005
Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparisonZoe Draelos, Anjuli Nayak, David Pariser, et al.
Journal of Drugs in Dermatology : JDD|August 21, 2018
Rapid Onset of Action in Patients With Moderate-to-Severe Plaque Psoriasis With Halobetasol 0.01%/Tazarotene 0.045% Fixed CombinationLinda Stein Gold, Leon H Kircik, David Pariser, et al.
Journal of Drugs in Dermatology : JDD|August 19, 2016
The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethasone Dipropionate Improves the Health-Related Quality of Life in Patients With Psoriasis Vulgaris: Results from the Randomized PSO-FAST StudyCraig Leonardi, Jerry Bagel, Paul Yamauchi, et al.
Journal of Drugs in Dermatology : JDD|December 15, 2015
Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients With Psoriasis Vulgaris--a Randomized Phase III Study (PSO-FAST)Craig Leonardi, Jerry Bagel, Paul Yamauchi, et al.
Journal of the American Academy of Dermatology|July 8, 2010
Long-term etanercept in pediatric patients with plaque psoriasisAmy S Paller, Elaine C Siegfried, Lawrence F Eichenfield, et al.
Dermatology and Therapy|May 11, 2025
Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient OutcomesBruce E Strober, Michael Bukhalo, April W Armstrong, et al.
Dermatology and Therapy|December 9, 2017
Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 StudiesDavid Pariser, Ellen Frankel, Joel Schlessinger, et al.
The Journal of Clinical and Aesthetic Dermatology|October 10, 2022
The Future of Contract Research Organizations in Dermatology and Aesthetic ResearchMark Nestor, David Pariser, James Del Rosso, et al.
The Journal of Clinical and Aesthetic Dermatology|January 2, 2023
The Future of Contract Research Organizations in Dermatology and Aesthetic ResearchMark Nestor, David Pariser, James Del Rosso, et al.
BMC Dermatology|May 9, 2015
Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasisFernando Valenzuela, Kim A Papp, David Pariser, et al.
Pageof 7